Announcements Trials
Browse Landscape

Phase

Phase 2 89Phase 3 10Phase 1/2 7Phase NA 5Phase 4 5Phase 1 3Phase 2/3 1

Status

Completed 18Unknown 3Withdrawn 1Terminated 1Active not recruiting 1

Sponsor Class

OTHER 2OTHER_GOV 1

Study Type

Interventional 3

Sponsor

Cancer Type

Gastrointestinal 3

Conditions

Stomach Neoplasms 3Neoplasm Metastasis 1Gastrointestinal Neoplasms 1Colorectal Neoplasms 1

Interventions

Cyclophosphamide 51fludarabine 38Injections 32Gemcitabine 25Paclitaxel 24Cisplatin 22Radiotherapy 19toripalimab 18pembrolizumab 18Carboplatin 17Capecitabine 17Fluorouracil 15Oxaliplatin 14Nivolumab 14Docetaxel 12camrelizumab 11apatinib 11Temozolomide 11Immunotherapy, Adoptive 11Cetuximab 11Bevacizumab 10Irinotecan 9Drug Therapy 9sintilimab 8Etoposide 8aldesleukin 7Taxes 7Rituximab 7Radiosurgery 7Peripheral Blood Stem Cell Transplantation 7

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

3 trials
RecentStart dateEnrollment
Phase 1 × Unknown × S 1 (combination) × Clear all
NCT03977220 2019-06-06

Nab-paclitaxel Combined With S-1 Treating Diffuse Type of Stage â…¢ Gastric Cancer

Shanghai Zhongshan Hospital

Phase 1 Unknown
20 enrolled
Gastrointestinal

Stomach Neoplasms

NCT03276156 2017-09-08

Apatinib in Combination With S-1 as Second-Line Treatment in Patients With Advanced Gastric Cancer

Zhejiang Cancer Hospital

Phase 1 Unknown
12 enrolled
Gastrointestinal

Stomach Neoplasms

NCT00506207 2007-07-25

TIROX

National Cancer Center, Korea

Phase 1 Unknown
23 enrolled
Gastrointestinal

Gastrointestinal Neoplasms, Neoplasm Metastasis, Stomach Neoplasms, Colorectal Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡